Delivery Order SPE2DB25D3504-SPE2DB25FVWKF
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,309.82 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The award was made on September 4, 2025, with a completion date of September 5, 2025, under a firm fixed-price contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $4,211.35 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL units), an insulin medication used in diabetes management. This contract represents a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and was awarded competitively with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $4,938.18 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,432.44 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL), an insulin medication commonly used for diabetes management. This firm fixed-price, competitively awarded contract was issued on June 5, 2025, with an ultimate completion date of June 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $3,463.19 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin on May 6, 2025, with completion scheduled for May 7, 2025. This delivery order represents a non-competitive, non-set-aside award under a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. The contract is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen's place of performance is its corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,410.43 for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), a rapid-acting insulin used for diabetes management. This competitively awarded, non-set-aside contract has a ceiling value of $12,920.59 and a firm fixed price structure, with an ultimate completion date of September 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of NovoLog 100 Unit/mL Vial 10mL insulin medication with a ceiling value of $1,354.18. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million through December 2026. The place of performance...